Related Experiment Video
Updated: Oct 13, 2025

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
Heparin-Binding Protein in Critically Ill Children With Severe Community-Acquired Pneumonia
Caizhi Huang1, Cong Zhang1, Jie Zhang1
1Department of Laboratory Medicine, Hunan Children's Hospital, Changsha, China.
Insights
Heparin-binding protein (HBP) shows promise in predicting respiratory failure and sepsis progression in children with severe community-acquired pneumonia (CAP). Higher HBP levels were independently associated with respiratory failure and outperformed other biomarkers in predicting severe sepsis.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Biomarker research
Background:
- Severe community-acquired pneumonia (CAP) in children can lead to critical complications like respiratory failure (RF) and sepsis.
- Identifying reliable biomarkers for early prediction of disease progression is crucial for timely intervention in critically ill children.
Purpose of the Study:
- To investigate the association between Heparin-binding protein (HBP) levels and the development of RF and sepsis in children with severe CAP.
- To evaluate HBP as a potential predictor of disease progression compared to established biomarkers.
Main Methods:
- A cohort of 157 critically ill children with severe CAP admitted to the ICU was studied.
- Plasma levels of HBP and other biomarkers (CRP, IL-6, procalcitonin, WBC, neutrophil percentage, D-dimer) were measured at ICU admission.
- Development of RF and sepsis was monitored throughout the ICU stay.
Main Results:
- Elevated HBP levels were observed in children with severe CAP.
- HBP, IL-6, and D-dimer significantly predicted RF development; high HBP was independently associated with RF.
- HBP demonstrated superior performance in predicting severe sepsis compared to other biomarkers, with high specificity and positive predictive value.
Conclusions:
- Heparin-binding protein (HBP) may serve as a valuable and potentially superior biomarker for predicting disease progression, including respiratory failure and severe sepsis, in children with severe CAP.
- Further research validating HBP's role in pediatric critical care is warranted.
Abstract:
Objective: The aim of this study was to investigate possible associations between Heparin-binding protein (HBP) and the development of respiratory failure (RF) and sepsis in critically ill children with severe community-acquired pneumonia (CAP). Methods: This study enrolled 157 children with severe CAP admitted to Intensive Care Unit (ICU). At ICU admission, the levels of HBP and other biomarkers, including C-reactive protein, interleukin-6 (IL-6), procalcitonin, white blood cells, neutrophil percentage, and D-dimer, were determined. Results: Of the enrolled patients, 106 developed RF (35 with RF at enrollment and 71 with RF after enrollment), while 51 did not developed RF. The number of patients progressing to sepsis in those with or without RF were 34 (21 with severe sepsis) and 14, respectively. The plasma level of HBP at admission was more than eightfold higher than the upper normal value. HBP, IL-6, and D-dimer could significantly predict the development of RF, and a high level of HBP (odds ratio = 1.008, 95% confidence interval: 1.003-1.013) was independently associated with the development of RF in this population. Compared with other biomarkers, HBP was the best indicator of progression to severe sepsis, with an area under the receiver operating characteristic curve of 0.85, the best specificity at 96.30%, and a positive predictive value of 92.86% at the optimal cut-off value of 340.29 ng/mL. The HBP level was also positively correlated with other conventional biomarkers. Conclusion: HBP might represent a better predictor of disease progression in children with severe CAP than currently used biomarkers.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Drug Distribution: Plasma Protein Binding
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

